Phoenix Based Paradigm And Viomics Acquired by Exact Sciences

On March 3, 2020, Exact Sciences Corp. (NASDAQ: EXAS) announced the completion of its acquisitions of Paradigm Diagnostics, Inc. and Viomics, Inc., two privately held companies based in Phoenix. Together, Paradigm and Viomics provide a differentiated late-stage therapy selection test and deep competencies in sequencing and biomarker discovery, extending Exact Sciences’ lab testing and research and development capabilities.Continue reading

New FDA Guidance Issued for Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications

On February 25, 2020, the FDA issued two Clinical Laboratory Improvement Amendments (CLIA) Waiver Applications related final guidance documents.

Continue reading

COVID-19 – Government and Industry Work Together to Address a Global Health Emergency

Biotech and Medtech innovators are working to find answers and provide support for people impacted by the Novel Corona Virus (COVID-19). As they work for develop and deliver solutions, get the latest on what you should know, situation updates and key information for travelers, healthcare professionals, the businesses from the Centers for Disease Control at the CDC Information Hub

Continue reading

Avery Therapeutics Co-founder and Chief Executive Officer named a Senior Member of the National Academy of Inventors

Jordan Lancaster is an assistant research scientist with the Sarver Heart Center and founder of Avery Therapeutics, which aims to advance tissue-engineered therapeutics to treat heart disease and muscle injuries. He holds three U.S. patents. Lancaster’s technologies include MyCardia, which is designed to make new blood vessels and “re-muscularize” the heart, making it perform better.Continue reading

Arizona Legislators – Champions for Children With Rare Diseases

Saturday, February 29, 2020 is Rare Disease Day. At the Arizona Legislature, SB1571 , sponsored by Senator Kate Brophy McGee, would expand Arizona’s ability to screen newborns for two serious and too often deadly rare  diseases, SMA and X-ALD so that they can be detected and treated early, providing there children with a better chance at healthier lives. The bill passed unanimously out of the Senate Health and Human Services Committee and is moving through the legislative process. Continue reading

Your Opportunity to Virtually Join the Arizona MedTech Thank You Tour

This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax.   AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In.  Even if you are not able to be with us LIVE in Washington, D.C.  you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading